Colorectal polyps in childhood

Current Opinion in Pediatrics

Volumn 24, Issue 5, 2012, Pages 632-637

  Thakkar, Kalpesh ^a   Fishman, Douglas S ^a   Gilger, Mark A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

colonic polyps; colonoscopy; gastrointestinal hemorrhage

Indexed keywords

CELECOXIB;

CANCER RISK; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COLON INTUSSUSCEPTION; COLONOSCOPY; COLORECTAL POLYP; DIAGNOSTIC IMAGING; DRUG EFFICACY; ETHNICITY; FAMILIAL COLON POLYPOSIS; GASTROINTESTINAL HEMORRHAGE; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; PEUTZ JEGHERS SYNDROME; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ADENOMATOUS POLYPS; ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COLONIC POLYPS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2 INHIBITORS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INFANT; INTESTINE, LARGE; INTUSSUSCEPTION; MALE; PEUTZ-JEGHERS SYNDROME; PREVALENCE; PYRAZOLES; SULFONAMIDES;

EID: 84866432671     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328357419f     Document Type: Review

References (39)

1. Durno CA. Colonic polyps in children and adolescents. Can J Gastroenterol 2007; 21:233-239.
2. Wang LC, Lee HC, Yeung CY, et al. Gastrointestinal polyps in children. Pediatr Neonatol 2009; 50:196-201.
3. Thakkar K, Alsarraj A, Fong E, et al. Prevalence of colorectal polyps in pediatric colonoscopy. Dig Dis Sci 2012; 57:1050-1055.
4. Elitsur Y, Teitelbaum JE, Rewalt M, et al. Clinical and endoscopic data in juvenile polyposis syndrome in preadolescent children: a multicenter experience from the United States. J Clin Gastroenterol 2009; 43:734-736.
5. Hood B, Bigler S, Bishop P, et al. Juvenile polyps and juvenile polyp syndromes in children: a clinical and endoscopic survey. Clin Pediatr (Phila) 2011; 50:910-915.
6. Fox VL, Perros S, Jiang H, et al. Juvenile polyps: recurrence in patients with multiple and solitary polyps. Clin Gastroenterol Hepatol 2010; 8:795-799.
7. Nugent KP, Talbot IC, Hodgson SV, et al. Solitary juvenile polyps: not a marker for subsequent malignancy. Gastroenterology 1993; 105:698-700.
8. Brosens LA, Langeveld D, van Hattem WA, et al. Juvenile polyposis syndrome. World J Gastroenterol 2011; 17:4839-4844.
9. Giardiello FM, Hamilton SR, Kern SE, et al. Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 1991; 66:971-975.
10. El-Hodhod MA, Soliman AA, Hamdy AM, et al. Fate and ultra-structural features of chicken skin mucosa around juvenile polyps. Acta Gastroenterol Belg 2011; 74:17-21.
11. Manfredi MA, Fox VL, Zurakowski D, et al. Matrix metalloproteinases in the urine and tissue of patients with juvenile polyps: potential biomarkers for the presence of polyps. J Pediatr Gastroenterol Nutr 2009; 48:405-411.
12. Jass JR, Williams CB, Bussey HJ, et al. Juvenile polyposis-a precancerous condition. Histopathology 1988; 13:619-630.
13. Desai DC, Neale KF, Talbot IC, et al. Juvenile polyposis. Br J Surg 1995; 82:14-17.
14. Zbuk KM, Eng C. Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol 2007; 4:492-502.
15. Friedl W, Uhlhaas S, Schulmann K, et al. Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 2002; 111:108-111.
16. Van Hattem WA, Langeveld D, de Leng WW, et al. Histologic variations in juvenile polyp phenotype correlate with genetic defect underlying juvenile polyposis. Am J Surg Pathol 2011; 35:530-536.
17. Brosens LA, van Hattem A, Hylind LM, et al. Risk of colorectal cancer in juvenile polyposis. Gut 2007; 56:965-967.
18. Dunlop MG. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile poly-posis, and Peutz-Jeghers syndrome. Gut 2002; 51 (Suppl. 5):V21-V27.
19. Van Lier MG, Wagner A, Mathus-Vliegen EM, et al. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 2010; 105:1258-1264; author reply 1265.
20. Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987; 316:1511-1514.
21. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119:1447-1453.
22. Boardman LA, Couch FJ, Burgart LJ, et al. Genetic heterogeneity in Peutz-Jeghers syndrome. Hum Mutat 2000; 16:23-30.
23. Beggs AD, Latchford AR, Vasen HF, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 2010; 59:975-986.
24. Sakamoto H, Yamamoto H, Hayashi Y, et al. Nonsurgical management of small-bowel polypsinPeutz-Jeghers syndrome with extensive polypectomy by using double-balloon endoscopy. Gastrointest Endosc 2011; 74:328-333.
25. Van Lier MG, Mathus-Vliegen EM, Wagner A, et al. High cumulative risk of intussusception in patients with Peutz-Jeghers syndrome: time to update surveillance guidelines? Am J Gastroenterol 2011; 106:940-945.
26. Schreibman IR, Baker M, Amos C, et al. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005; 100:476-490.
27. Latchford AR, Neale K, Phillips RK, et al. Peutz-Jeghers syndrome: intriguing suggestion of gastrointestinal cancer prevention from surveillance. Dis Colon Rectum 2011; 54:1547-1551.
28. Wallis YL, Morton DG, McKeown CM, et al. Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet 1999; 36:14-20.
29. Bisgaard ML, Fenger K, Bulow S, et al. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994; 3:121-125.
30. Bulow S. Results of national registration of familial adenomatous polyposis. Gut 2003; 52:742-746.
31. Bulow S. Familial adenomatous polyposis. Ann Med 1989; 21:299-307.
32. Vasen HF, Moslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57:704-713.
33. Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous poly-posis (AFAP). A review of the literature. Fam Cancer 2003; 2:43-55.
34. Lynch PM, Ayers GD, Hawk E, et al. The safety and efficacy of celecoxib in children with familial adenomatous polyposis. Am J Gastroenterol 2010; 105:1437-1443.
35. Munck A, Gargouri L, Alberti C, et al. Evaluation of guidelines for management of familial adenomatous polyposis in a multicenter pediatric cohort. J Pediatr Gastroenterol Nutr 2011; 53:296-302.
36. Douma KF, Aaronson NK, Vasen HF, et al. Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature. Psychooncology 2008; 17:737-745.
37. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997; 336:823-827.
38. Duncan RE, Gillam L, Savulescu J, et al. The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis. Fam Cancer 2010; 9:27-35.
39. Bulow S, Bulow C, Nielsen TF, et al. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adeno-matous polyposis. Results from the Danish Polyposis Register. Scand J Gastroenterol 1995; 30:989-993.